60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) — Cash Flow-to-Debt Ratio
60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) has a Cash Flow-to-Debt Ratio of -1.27x as of June 2026, meaning its operating cash flow of $-2.23 Million could theoretically repay -1% of its total liabilities ($1.75 Million) in one year. See how financially flexible is 60 Degrees Pharmaceuticals, Inc. Common to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
60 Degrees Pharmaceuticals, Inc. Common Stock Cash Flow-to-Debt Ratio (2020–2025)
Historical debt coverage capacity for 60 Degrees Pharmaceuticals, Inc. Common Stock across 6 annual periods. For the full cash flow conversion analysis, see 60 Degrees Pharmaceuticals, Inc. Common operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for 60 Degrees Pharmaceuticals, Inc. Common Stock (2020–2025)
Year-by-year debt coverage analysis for 60 Degrees Pharmaceuticals, Inc. Common Stock. Check 60 Degrees Pharmaceuticals, Inc. Common (SXTP) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.45x | $-6.85 Million | $1.99 Million | ▼ -10.1% |
| 2024 | -3.13x | $-5.65 Million | $1.80 Million | ▼ -105.7% |
| 2023 | -1.52x | $-4.54 Million | $2.99 Million | ▼ -3733.6% |
| 2022 | -0.04x | $-1.01 Million | $25.45 Million | ▼ -19.5% |
| 2021 | -0.03x | $-649.11K | $19.55 Million | ▼ -310.4% |
| 2020 | -0.01x | $-167.30K | $20.68 Million | — |